Stereotactic body radiation therapy plus chemotherapy improves survival among stage 4 lung cancer patients
(UT Southwestern Medical Center) A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Health | International Medicine & Public Health | Lung Cancer | Radiation Therapy